Compounded vs Brand-Name GLP-1: What's the Difference?

If you've researched GLP-1 weight loss at all, you've seen two price tiers: brand-name Wegovy or Zepbound at ~$1,100–1,400 per month, and "compounded" versions through telehealth starting under $200. The 7–10x price gap makes people suspicious — are compounded versions actually the same medication? The honest answer is "the same active ingredient, prepared differently, regulated differently." This guide walks through what that actually means.

Quick comparison

What "compounded" actually means

A compounded medication is prepared for a specific patient by a licensed pharmacist. This is an old practice — pharmacists have been compounding for centuries. A pharmacist might combine two medications for a patient allergic to an inactive ingredient, prepare a liquid version of a pill for a child who can't swallow, or (as with GLP-1s right now) prepare an active ingredient during a drug shortage when the branded product isn't available.

Under federal law (the Drug Quality and Security Act, 2013), compounding falls into two categories:

503A compounding pharmacies prepare medications per individual prescription. They're regulated by state pharmacy boards and must follow USP <797> standards for sterile compounding.

503B outsourcing facilities prepare medications in larger batches, have stricter FDA oversight, and can ship to multiple prescribers. These are the facilities most telehealth GLP-1 programs use.

Both are legal, both are regulated, both have compliance requirements for purity testing, sterility, and sourcing.

What "FDA shortage list" has to do with it

Under normal conditions, compounding pharmacies cannot legally prepare a version of a drug that's commercially available as an FDA-approved product. There are two exceptions:

1. The branded drug is on the FDA shortage list. When an FDA-approved drug is in short supply, compounding pharmacies can prepare the same active ingredient to meet patient demand.

2. There's a specific clinical reason the patient can't use the approved version. For example, an allergy to an inactive ingredient in the branded formulation.

Semaglutide has been on the FDA shortage list since 2022 due to extreme demand for Ozempic and Wegovy. Tirzepatide was briefly added, briefly removed in October 2024, then added back. This is why compounded semaglutide and tirzepatide are currently legal and widely available through telehealth — the approved products aren't meeting demand.

Is the active ingredient literally the same?

Yes. Semaglutide is a specific molecule with a defined chemical structure. Tirzepatide is another specific molecule. Whether that molecule is packaged in a Novo Nordisk pen or prepared by a 503B compounding facility, the molecule itself is identical.

What differs is:

• Concentration and dose presentation — a Wegovy pen delivers a specific volume per click; a compounded vial requires drawing up a specific volume with a syringe. Your provider tells you exactly how much to draw
• Inactive ingredients — preservatives, buffers, and carriers vary. Brand-name uses a specific FDA-approved formulation; compounded versions may vary by pharmacy
• Testing protocols — brand-name goes through batch release testing at FDA-inspected manufacturing sites. Compounded versions are tested to USP standards and state pharmacy board requirements, which are rigorous but different
• Packaging and stability data — brand-name has extensive stability data behind specific storage conditions; compounded versions typically have shorter expiration windows

What's actually different in practice

Injection experience

Brand-name Wegovy and Zepbound come as pre-filled injection pens — you twist the dose, inject, done. Very user-friendly.

Compounded semaglutide typically comes as a vial with a separate syringe. You draw up the correct volume, then inject. Slightly more steps but takes 30 seconds with practice. Some compounding pharmacies now offer pre-filled pens.

Dose flexibility

Pens have fixed dose increments — a Wegovy pen goes 0.25, 0.5, 1.0, 1.7, 2.4 mg per injection and you can't easily deviate.

Compounded vials let a provider prescribe non-standard doses — say, 0.75 mg when you're having trouble at 1.0 mg but fine at 0.5 mg. This flexibility can be valuable if you're sensitive to titration.

Reliability of supply

Brand-name is subject to pharmacy stocking and insurance prior auth delays. Even when covered, patients routinely wait days or weeks for refills.

Compounded via telehealth is typically shipped directly to you on a predictable monthly cadence. No pharmacy pickup, no prior auth wrestling.

Long-term safety data

Brand-name Wegovy has been used by millions of patients since FDA approval in 2021. There's extensive post-market safety data.

Compounded versions use the same active ingredient, so the drug-level safety data applies — but the specific compounded formulations don't have the same decade-plus tracking. Most compounded semaglutide in widespread use today has been around since 2022–2023.

Common misconceptions

"Compounded means generic." No — these are legally and regulatorily distinct. Generics are FDA-approved copies of brand drugs (there are no generic GLP-1s yet). Compounded medications are prepared per prescription by licensed pharmacies under compounding regulations.

"Compounded isn't regulated." It is — by state boards of pharmacy, the FDA's compounding rules, and USP standards. It's regulated differently than brand-name drugs, which go through FDA new drug approval.

"Compounded is lower quality." Not inherently. A reputable 503B outsourcing facility follows strict sterility, potency, and testing protocols. Some compounded products are better than others depending on the facility. The variability is real but doesn't mean compounded is categorically worse.

"The FDA says compounded GLP-1s are unsafe." The FDA has issued warnings about specific risks — unapproved salt forms like semaglutide sodium that don't match the FDA-approved base, and pharmacies operating outside compounding rules. These warnings are legitimate. They don't mean all compounded GLP-1s are unsafe — they mean patients should use reputable programs that source from 503B facilities using the correct base form.

"If it's so much cheaper, it must be inferior." Brand-name pricing reflects R&D recovery, advertising, and negotiation with insurance. The active ingredient itself doesn't cost much to produce. Compounded pricing removes the brand markup.

How to evaluate a compounded telehealth program

Not all compounded GLP-1 programs are equal. When evaluating one, ask:

1. What pharmacy do you use? Reputable programs partner with specific 503B outsourcing facilities or high-quality 503A pharmacies. They should be able to name the pharmacy and its licensing.
2. What form of semaglutide do you use? The answer should be "semaglutide" or "semaglutide base." Be cautious of "semaglutide sodium" or "semaglutide acetate" — these are different salt forms not used in the FDA-approved product, and the FDA has flagged them specifically.
3. Are your providers licensed in my state? Required for legitimate telehealth prescribing. Should be a straightforward yes.
4. What happens if the shortage ends? A good program has a contingency plan — migration to brand-name, or a transition window.
5. Can I message a provider between scheduled visits? Especially during titration, provider accessibility matters more than most other features.

Brand vs compounded: which is right for you?

Choose brand-name if:

• You have insurance that covers Wegovy or Zepbound (copay often $25–$150)
• You want the longest post-market safety track record
• You strongly prefer the pen form factor
• Cost isn't a primary constraint

Choose compounded via telehealth if:

• You don't have insurance coverage for weight-loss GLP-1s
• Brand-name cash pricing is out of budget (most people)
• You're comfortable with vial + syringe injection
• You want predictable monthly delivery
• You understand the regulatory tradeoffs

Either works if:

• You have a provider you trust to guide the choice
• You're willing to switch if one stops working or becomes unavailable

For a deeper look at pricing specifically, see how much semaglutide costs without insurance. For the clinical differences between the two major GLP-1 options, see semaglutide vs tirzepatide.

Frequently asked questions

Will compounded semaglutide work as well for weight loss? The active ingredient is the same, so the pharmacology is the same. In practice, patients on compounded versions report weight loss comparable to published brand-name trial data. No head-to-head clinical trial has been conducted, but the biological mechanism is identical.

Is compounded semaglutide safe? When sourced from a reputable compounding pharmacy using FDA-recognized semaglutide (not salt forms), the safety profile mirrors brand-name. Risks come from non-reputable sources — pharmacies without proper licensing, unapproved salt forms, or products sold outside the telehealth provider relationship.

Can I switch from compounded to brand-name later? Yes, routinely. Your provider can transition you to a brand-name prescription. Your current dose translates directly. The only adjustment is billing and pharmacy routing.

Does my HSA/FSA cover compounded medications? Typically yes — they're prescription healthcare expenses. Most telehealth platforms provide receipts suitable for HSA/FSA reimbursement. Check with your specific administrator.

What if the FDA removes semaglutide from the shortage list? Compounding pharmacies generally cannot accept new patients after a drug leaves the shortage list, though existing patients often have a transition period. You'd need to switch to brand-name (with insurance or cash pay) or a different treatment. This is a real risk worth planning for.

Is it legal to buy compounded GLP-1 online? Yes, when prescribed by a licensed provider and dispensed by a licensed pharmacy in a state where telehealth prescribing is legal for this category. Pallas (and reputable competitors) operate within these boundaries. "Peptide companies" selling research chemicals or semaglutide without a prescription are not legitimate and are operating illegally.

---

Bottom line: Compounded and brand-name GLP-1s contain the same active compound, regulated through different frameworks. Compounded is cheaper, equally effective for most patients, but carries supply-side risk tied to the FDA shortage designation. Brand-name is more expensive, more reliable supply-wise, and has longer track record. Most patients without insurance coverage reasonably choose compounded; most patients with coverage should use the covered brand-name option.